Back to search

Georgia Institute of Technology

Enhancing immune checkpoint blockade and cancer immunotherapy via tissue targeting and biomaterial nanoparticles

Abstract

dc:description.abstract

Immune checkpoint blockade (ICB) has emerged in recent years as one of the most promising new cancer therapies. However, a significant majority of patients receiving these therapies 1) do not respond, 2) experience adverse side effects, or 3) respond initially but relapse. Overcoming these limitations is therefore a critical hurdle in improving these treatments. Checkpoint pathways are active in both the tumor microenvironment and lymphoid tissues where they prevent T cell cytotoxic function and activation, respectively. While improving tumor and lymphoid delivery of these therapies offers a promising approach to advance the efficacy of ICB, clinical applications of ICB have so far only relied on systemic administrations, which often result in poor tumor and lymphoid accumulation. Additionally, administration of combination immunotherapies outside of ICB is challenging as many of these drugs are short-lived in vivo, are insoluble in aqueous solvents, and are not targeted to the cells of interest leading to off-target side effects. Given the current state of ICB therapy, the focus of this thesis work is to address the drug delivery barriers associated with conventional systemic administrations and non-targeted delivery of immune modulators. This work explored two unique delivery strategies: one which proposes drugging tumor draining lymph nodes with ICB therapies by way of lymphatics using local rather than systemic administrations to enhance anti-tumor efficacy; and the second which proposes a novel drug-eluting ICB platform by engineering an antibody-nanoparticle conjugate system for improved T cell targeting and sustained delivery of small molecule immunotherapies.

Degree

thesis:*
Level thesis:degree_level
Doctoral
Department dc:contributor.department
Chemical and Biomolecular Engineering
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Francis, David
Committee members dc:contributor.committeemember
  • Thomas, Susan N
  • Champion, Julie
  • Prausnitz, Mark
  • Roy, Krish
  • Waller, Ned

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1853/64974

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Francis, David. Enhancing immune checkpoint blockade and cancer immunotherapy via tissue targeting and biomaterial nanoparticles. Doctoral thesis, Georgia Institute of Technology, 2020. http://hdl.handle.net/1853/64974